Follow-up of loci from the International Genomics of Alzheimer's Disease Project identifies TRIP4 as a novel susceptibility gene

A Ruiz, S Heilmann, T Becker, I Hernandez, H Wagner, M Thelen, A Mauleon, M Rosende-Roca, C Bellenguez, JC Bis, D Harold, A Gerrish, R Sims, O Sotolongo-Grau, A Espinosa, M Alegret, JL Arrieta, A Lacour, M Leber, J BeckerA Lafuente, S Ruiz, L Vargas, O Rodriguez, G Ortega, MA Dominguez, R Mayeux, JL Haines, MA Pericak-Vance, LA Farrer, GD Schellenberg, V Chouraki, LJ (Lenore) Launer, Cornelia Duijn, S Seshadri, C Antunez, Monique Breteler, M Serrano-Rios, F Jessen, L Tarraga, MM Nothen, W Maier, M Boada, A Ramirez

Research output: Contribution to journalArticleAcademicpeer-review

70 Citations (Scopus)
3 Downloads (Pure)


To follow-up loci discovered by the International Genomics of Alzheimer's Disease Project, we attempted independent replication of 19 single nucleotide polymorphisms (SNPs) in a large Spanish sample (Fundacio ACE data set; 1808 patients and 2564 controls). Our results corroborate association with four SNPs located in the genes INPP5D, MEF2C, ZCWPW1 and FERMT2, respectively. Of these, ZCWPW1 was the only SNP to withstand correction for multiple testing (P = 0.000655). Furthermore, we identify TRIP4 (rs74615166) as a novel genome-wide significant locus for Alzheimer's disease risk (odds ratio = 1.31; confidence interval 95% (1.19-1.44); P = 9.74 x 10(-9)).
Original languageUndefined/Unknown
JournalTranslational Psychiatry
Publication statusPublished - 2014

Cite this